0001493152-22-007499.txt : 20220323
0001493152-22-007499.hdr.sgml : 20220323
20220323074734
ACCESSION NUMBER: 0001493152-22-007499
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220321
FILED AS OF DATE: 20220323
DATE AS OF CHANGE: 20220323
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Verwijs Marinus
CENTRAL INDEX KEY: 0001916553
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40544
FILM NUMBER: 22761603
MAIL ADDRESS:
STREET 1: C/O AEROVATE THERAPEUTICS, INC.
STREET 2: 200 BERKELEY STREET, FLOOR 18
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aerovate Therapeutics, Inc.
CENTRAL INDEX KEY: 0001798749
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831377888
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 BERKELEY STREET
STREET 2: FLOOR 18
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-443-2400
MAIL ADDRESS:
STREET 1: 200 BERKELEY STREET
STREET 2: FLOOR 18
CITY: BOSTON
STATE: MA
ZIP: 02116
4
1
ownership.xml
X0306
4
2022-03-21
0
0001798749
Aerovate Therapeutics, Inc.
AVTE
0001916553
Verwijs Marinus
C/O AEROVATE THERAPEUTICS, INC.
930 WINTER STREET, SUITE M-500
WALTHAM,
MA
02451
0
1
0
0
Senior Vice President, CMC
Stock Option (Right to Buy)
14.59
2022-03-21
4
A
0
90000
0
A
2032-03-20
Common Stock
90000
90000
D
25% of this option shall vest and become exercisable on March 21, 2023, with the remainder vesting in 36 substantially equal monthly installments.
/s/ George A. Eldridge, Attorney-in-Fact
2022-03-23